A drastic reduction in the life span of cystatin C L68Q carriers due to life-style changes during the last two centuries
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bjornsson, Hans Tomas
Bragason, Birkir Thor
MetadataShow full item record
CitationPLoS Genet. 2008, 4(6):e1000099
AbstractHereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disease with high penetrance, manifest by brain hemorrhages in young normotensive adults. In Iceland, this condition is caused by the L68Q mutation in the cystatin C gene, with contemporary carriers reaching an average age of only 30 years. Here, we report, based both on linkage disequilibrium and genealogical evidence, that all known copies of this mutation derive from a common ancestor born roughly 18 generations ago. Intriguingly, the genealogies reveal that obligate L68Q carriers born 1825 to 1900 experienced a drastic reduction in life span, from 65 years to the present-day average. At the same time, a parent-of-origin effect emerged, whereby maternal inheritance of the mutation was associated with a 9 year reduction in life span relative to paternal inheritance. As these trends can be observed in several different extended families, many generations after the mutational event, it seems likely that some environmental factor is responsible, perhaps linked to radical changes in the life-style of Icelanders during this period. A mutation with such radically different phenotypic effects in reaction to normal variation in human life-style not only opens the possibility of preventive strategies for HCCAA, but it may also provide novel insights into the complex relationship between genotype and environment in human disease.
DescriptionTo access full text version of this article. Please click on the hyperlink "View/Open" at the bottom of this page
- Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fluids and monocyte cultures by MS.
- Authors: Asgeirsson B, Haebel S, Thorsteinsson L, Helgason E, Gudmundsson KO, Gudmundsson G, Roepstorff P
- Issue date: 1998 Feb 1
- Two stable unfolding intermediates of the disease-causing L68Q variant of human cystatin C.
- Authors: Gerhartz B, Ekiel I, Abrahamson M
- Issue date: 1998 Dec 8
- The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids.
- Authors: Bjarnadottir M, Nilsson C, Lindström V, Westman A, Davidsson P, Thormodsson F, Blöndal H, Gudmundsson G, Grubb A
- Issue date: 2001 Mar
- Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects.
- Authors: Palsdottir A, Snorradottir AO, Thorsteinsson L
- Issue date: 2006 Jan
- The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage.
- Authors: Olafsson I, Thorsteinsson L, Jensson O
- Issue date: 1996 Apr